Great British Academy of Aesthetic Medicine, London, UK.
University College London, London, UK.
J Cosmet Dermatol. 2021 Jun;20(6):1867-1874. doi: 10.1111/jocd.13750. Epub 2020 Oct 31.
Microneedling in combination with the use of growth factors can help with a range of indications, including skin rejuvenation. There is an increase in request for safe minimally invasive procedures with no-to-minimal downtime. This procedure offers regeneration and is becoming popular as part of the regenerative, minimally invasive era.
To examine the efficacy of a course of two sessions of growth factor-induced therapy using propriety preparation of AQ recovery serum.
Thirty women with various ethnic backgrounds (Chinese, Caucasian and Latino) with an average age of 38 years old participated and mild-moderate visual facial aging signs Two sessions with 2-week intervals were completed using a derma stamp (transdermal drug delivery method) and 2 mL of growth factor serum (AQ Skin Solution recovery serum-contain a mixture of contains a mix of transforming growth factor beta (TGF-β), granulocyte monocyte-colony-stimulating factor, and platelets-derived growth factor with patented technology for extraction and composition at each session. The procedures were carried out for anti-aging and skin rejuvenation. Clinical assessment, VISIA photography, independent assessment of before and after photographs baseline and six weeks by two clinicians and two laypersons were carried out. The participants used FACE-Q questionnaire (outcome satisfaction) and scored changes in terms of their skin texture, radiance, pore size, wrinkles, pigmentation, tightness and overall skin appearance.
Physician's global assessment revealed growth factor-induced therapy resulted in skin rejuvenation in all races with 95% confidence, and this increased to 98% confidence for Latinos and Caucasians within the six weeks. Participants' subjective rating revealed improvement of overall skin appearance with 95% confidence. Most noted improvements were in brightness, skin texture, and tightness.
This study revealed improvement in overall skin appearance, brightness, skin texture, and tightness. The treatment is non-invasive, safe, with no or minimal downtime and resulted in high participant satisfaction.
微针与生长因子的联合应用可治疗多种疾病,包括皮肤年轻化。目前,人们对微创、非停工期或停工期极短的安全治疗方案的需求增加。该方案具有再生作用,作为再生、微创时代的一部分,越来越受欢迎。
评估使用专有 AQ 恢复血清制剂的生长因子诱导治疗两疗程的疗效。
30 名不同种族(中国、白种人和拉丁裔)的女性参与了该研究,平均年龄为 38 岁,患有轻度至中度视觉面部老化迹象。使用微针(经皮药物递送方法)和 2 mL 生长因子血清(AQ 皮肤解决方案恢复血清)进行两疗程治疗,间隔 2 周。2 毫升生长因子血清中含有转化生长因子-β(TGF-β)、粒细胞-单核细胞集落刺激因子和血小板衍生生长因子的混合物,采用专利技术进行提取和成分组合。治疗目的为抗衰老和皮肤年轻化。在基线和 6 周时,由两名临床医生和两名非专业人员进行临床评估、VISIA 摄影、独立评估照片前后变化。参与者使用 FACE-Q 问卷(结果满意度)对皮肤质地、光泽度、毛孔大小、皱纹、色素沉着、紧致度和整体皮肤外观的变化进行评分。
医生总体评估显示,生长因子诱导治疗在所有种族中均使皮肤年轻化,置信区间为 95%,在 6 周内,拉丁裔和白种人的置信区间增加到 98%。参与者的主观评分显示,整体皮肤外观改善,置信度为 95%。最明显的改善是皮肤的光泽度、质地和紧致度。
本研究显示,整体皮肤外观、光泽度、皮肤质地和紧致度均有改善。该治疗方案是非侵入性的、安全的,非停工期或停工期极短,且参与者满意度高。